Voloridge Investment Management
RYTM icon

Voloridge Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Voloridge Investment Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,575
Closed -$6.48M – 1243
2025
Q4 		$6.48M Sell
60,575
-307,688
-84% -$32.6M 0.02% 695
2025
Q3 		$37.2M Buy
368,263
+29,459
+9% +$2.73M 0.12% 201
2025
Q2 		$21.4M Sell
338,804
-84,064
-20% -$5.15M 0.08% 304
2025
Q1 		$22.4M Buy
422,868
+42,331
+11% +$2.35M 0.08% 323
2024
Q4 		$21.3M Buy
380,537
+27,214
+8% +$1.5M 0.08% 336
2024
Q3 		$18.5M Sell
353,323
-108,865
-24% -$5.22M 0.07% 397
2024
Q2 		$19M Sell
462,188
-11,267
-2% -$450K 0.07% 384
2024
Q1 		$20.5M Buy
473,455
+110,738
+31% +$4.85M 0.07% 327
2023
Q4 		$16.7M Buy
362,717
+342,350
+1,681% +$10.8M 0.07% 362
2023
Q3 		$467K Buy
+20,367
New +$456K ﹤0.01% 1221
2023
Q2 		– Sell
-193,590
Closed -$3.45M – 1538
2023
Q1 		$3.45M Sell
193,590
-1,406
-0.7% -$35.3K 0.02% 798
2022
Q4 		$5.68M Sell
194,996
-48,412
-20% -$1.24M 0.03% 602
2022
Q3 		$5.96M Buy
+243,408
New +$4.53M 0.03% 591
2021
Q1 		– Sell
-7,175
Closed -$213K – 1623
2020
Q4 		$213K Sell
7,175
-29,794
-81% -$757K ﹤0.01% 1264
2020
Q3 		$801K Buy
+36,969
New +$848K 0.01% 1002

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Voloridge Investment Management's RYTM Position: Q1 2026 in Review

Voloridge Investment Management sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 60,575 shares — an estimated $6.48M sold.

Voloridge Investment Management first reported a position in RYTM in Q3 2020 and held it in 15 quarters. The position peaked at $37.2M in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Voloridge Investment Management reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 60,575 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $6.48M.
  • Voloridge Investment Management first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 15 quarters.
  • Voloridge Investment Management's Rhythm Pharmaceuticals position peaked at $37.2M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.